NORWEGIAN CRUISE LINE HOLDINGS LTD. Issues Press Release Regarding Financial Results

On October 31, 2024, Norwegian Cruise Line Holdings Ltd. released a press statement detailing its financial performance for the quarter ending on September 30, 2024. The company reported positive revenue growth, with an increase of 5% to reach $1.6 billion. Diluted earnings per share (EPS) were recorded at $1.38, while Adjusted Diluted EPS stood at $0.87. Adjusted EBITDA for the quarter was reported to be $459 million, which included $51 million from IPR&D and milestones.

In the press release, the company highlighted various areas of its business, including its Women’s Health, Biosimilars, and Established Brands segments. Noteworthy developments in Women’s Health included steady growth in Nexplanon and Fertility products, offsetting the anticipated impact from generics on NuvaRing. The Biosimilars segment saw traction in Hadlima following its launch in the United States, while performance of Ontruzant reflected tender timing in Brazil and lower demand in the U.S. and Europe.

Within the Established Brands category, the company reported improvements due to new migraine products and recovering sales in injectable steroids, counterbalancing negative pricing trends in Japan. Additionally, the company reported positive progress in containing operating costs, lessening the pressure on gross margins.

Looking ahead, Norwegian Cruise Line Holdings Ltd. anticipates 2024 to mark the third consecutive year of revenue growth when adjusted for currency fluctuations. The company projects a revenue range of $6.375 billion to $6.425 billion for the full year, with expectations of around 3.1% to 3.8% growth at constant currency rates. The company’s guidance for adjusted EBITDA margin for the full year was revised upwards to account for IPR&D expenses and product mix considerations.

Furthermore, the discussions outlined in the press release shed light on the company’s detailed financial breakdown, showcasing its profit margins, research and development investments, net income adjustments, and the reconciliation of GAAP-reported figures to non-GAAP adjusted metrics.

In summary, Norwegian Cruise Line Holdings Ltd.’s recent financial report highlights a positive trajectory in its financial performance, signaling resilience and adaptability in navigating market challenges and opportunities within its diverse portfolio of offerings.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Norwegian Cruise Line’s 8K filing here.

Norwegian Cruise Line Company Profile

Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally. The company operates through the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands. It offers itineraries ranging from three days to a 180-days calling on various ports, including Scandinavia, Northern Europe, the Mediterranean, the Greek Isles, Alaska, Canada and New England, Hawaii, Asia, Tahiti and the South Pacific, Australia and New Zealand, Africa, India, South America, the Panama Canal, and the Caribbean.